Compounds > 2,2-bis(4-glycidyloxyphenyl)propane
Page last updated: 2024-10-23

2,2-bis(4-glycidyloxyphenyl)propane and Autoimmune Diabetes

2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Autoimmune Diabetes in 1 studies

2,2-bis(4-glycidyloxyphenyl)propane: structure

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Botolin, S1
McCabe, LR1

Other Studies

1 other study available for 2,2-bis(4-glycidyloxyphenyl)propane and Autoimmune Diabetes

ArticleYear
Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss.
    Journal of cellular physiology, 2006, Volume: 209, Issue:3

    Topics: Adipocytes; Animals; Benzhydryl Compounds; Biomarkers; Bone Marrow; Cell Differentiation; Cells, Cul

2006